PC
Polar Capital Portfolio holdings
AUM
$13.5B
1-Year Return
55.85%
This Quarter Return
+7.24%
1 Year Return
+55.85%
3 Year Return
+125.38%
5 Year Return
+259.12%
10 Year Return
–
AUM
$7.28B
AUM Growth
+$721M
(+11%)
Cap. Flow
+$275M
Cap. Flow
% of AUM
3.78%
Top 10 Holdings %
Top 10 Hldgs %
22.14%
Holding
282
New
28
Increased
103
Reduced
67
Closed
44
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
$129M |
| 2 |
Medtronic
MDT
|
$70.6M |
| 3 |
Becton Dickinson
BDX
|
$54M |
| 4 |
RTX Corp
RTX
|
$52.4M |
| 5 |
Humana
HUM
|
$47M |
Top Sells
| 1 |
Merck
MRK
|
$82.5M |
| 2 |
Baxter International
BAX
|
$49.3M |
| 3 |
Incyte
INCY
|
$41.9M |
| 4 |
Boston Scientific
BSX
|
$34.9M |
| 5 |
Stryker
SYK
|
$34.6M |
Sector Composition
| 1 | Financials | 23.88% |
| 2 | Healthcare | 23.8% |
| 3 | Technology | 20.4% |
| 4 | Communication Services | 10.37% |
| 5 | Industrials | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
AbbVie
ABBV
$376B
| – | – |
-80,000
| Closed | -$5.21M |
|
227
Agnico Eagle Mines
AEM
$74.5B
| – | – |
-121,369
| Closed | -$5.13M |
|
228
Akamai
AKAM
$11.1B
| – | – |
-91,177
| Closed | -$5.44M |
|
|
229
Baxter International
BAX
$12.1B
| – | – |
-951,223
| Closed | -$49.3M |
|
|
BLUE
230
DELISTED
bluebird bio
BLUE
| – | – |
-1,544
| Closed | -$1.82M |
|
231
Bristol-Myers Squibb
BMY
$95B
| – | – |
-190,000
| Closed | -$10.3M |
|
232
Cisco
CSCO
$269B
| – | – |
-502,934
| Closed | -$17M |
|
|
DHC
233
Diversified Healthcare Trust
DHC
$939M
| – | – |
-100,000
| Closed | -$2.02M |
|
234
Healthpeak Properties
DOC
$12.5B
| – | – |
-100,000
| Closed | -$3.13M |
|
235
Haemonetics
HAE
$2.61B
| – | – |
-474,024
| Closed | -$19.2M |
|
236
Healthcare Services Group
HCSG
$1.14B
| – | – |
-38,372
| Closed | -$1.65M |
|
|
HIMX
237
Himax Technologies
HIMX
$1.45B
| – | – |
-364,618
| Closed | -$3.32M |
|
238
Hecla Mining
HL
$5.93B
| – | – |
-863,162
| Closed | -$4.48M |
|
239
Intuitive Surgical
ISRG
$163B
| – | – |
-235,206
| Closed | -$20M |
|
240
McKesson
MCK
$86B
| – | – |
-68,657
| Closed | -$10.2M |
|
241
Pediatrix Medical
MD
$1.48B
| – | – |
-488,472
| Closed | -$33.9M |
|
242
Medical Properties Trust
MPW
$2.67B
| – | – |
-220,000
| Closed | -$2.83M |
|
243
Neurocrine Biosciences
NBIX
$13.9B
| – | – |
-185,000
| Closed | -$8.01M |
|
|
NGD
244
New Gold Inc
NGD
$4.86B
| – | – |
-1,165,212
| Closed | -$3.55M |
|
245
National Health Investors
NHI
$3.67B
| – | – |
-25,000
| Closed | -$1.82M |
|
246
Omega Healthcare
OHI
$12.6B
| – | – |
-50,000
| Closed | -$1.65M |
|
247
Impinj
PI
$5.47B
| – | – |
-85,280
| Closed | -$2.58M |
|
248
Prothena Corp
PRTA
$442M
| – | – |
-30,000
| Closed | -$1.67M |
|
249
Qualcomm
QCOM
$172B
| – | – |
-64,478
| Closed | -$3.7M |
|
250
Ultragenyx Pharmaceutical
RARE
$3.01B
| – | – |
-114,000
| Closed | -$7.73M |
|